Page 106 - ITPS-8-2
P. 106

INNOSC Theranostics and
            Pharmacological Sciences                                        Fungal markers in intracranial fungal infections



            only the importance of fungal markers in early diagnosis   paper has been uploaded to ResearchGate (doi: 10.13140/
            could be assessed and not treatment efficacy.      RG.2.2.33961.61287).
            4. Conclusion                                      References

            Given the limited data on fungal infections in Pakistan   1.   Murthy JMK, Sundaram C. Fungal infections of the central
            and the lack of IFI-centered studies, the epidemiology is   nervous system. Handb Clin Neurol. 2013;121:1383-1401.
            largely unknown. Consequently, the diagnostic approach is      doi: 10.1016/b978-0-7020-4088-7.00095-x
            suboptimal. Although imaging studies and biopsy are the   2.   De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions
            gold standards for IFI diagnosis, the gap in noninvasive   of invasive fungal disease from the European organization for
            modalities must be assessed. Our findings highlight the   research and treatment of cancer/invasive fungal infections
            importance of serological fungal biomarkers (GM and   cooperative group and the national institute of allergy and
            BDG) and CSF analysis as adjuncts to the gold standard   infectious diseases mycoses study group (EORTC/MSG)
            diagnostic tools. Furthermore, we propose the inclusion   consensus group. Clin Infect Dis. 2008;46(12):1813-1821.
            of fungal biomarker assays using CSF specimens in future      doi: 10.1086/588660
            diagnostic protocols.
                                                               3.   Chen M, Chen C, Yang Q, Zhan R. Candida meningitis in
            Acknowledgments                                       neurosurgical patients: A single-institute study of nine cases
                                                                  over 7 years. Epidemiol Infect. 2020;148:e148.
            None.
                                                                  doi: 10.1017/s0950268820001144
            Funding                                            4.   Krishnan S, Manavathu EK, Chandrasekar PH. Aspergillus

            None.                                                 flavus: An emerging non-fumigatus  Aspergillus species of
                                                                  significance. Mycoses. 2009;52(3):206-222.
            Conflict of interest                                  doi: 10.1111/j.1439-0507.2008.01642.x

            The authors declare that they have no competing interests.  5.   Rasoolinejad M, Hajiabdolbaghi M, Manshadi SAD,
                                                                  Ardalan FA, Moradnejad P, Alijani N. Cerebral aspergillosis
            Author contributions                                  in  an  immunocompetent  patient:  A  case  report.  Arch

            Conceptualization: Suneel Kumar, Zuhaa Rehman         Neurosci. 2015;3(2):e31710.
            Formal analysis: Zuhaa Rehman                         doi: 10.5812/archneurosci.31710
            Investigation: Suneel Kumar, Naeemullah Bullo, Munir Afzal  6.   Muñoz P, Guinea J, Bouza E. Update on invasive
            Methodology: Zuhaa Rehman, Suneel Kumar               aspergillosis: Clinical and diagnostic aspects. Clin Microbiol
            Writing–original draft:  Zuhaa Rehman, Anabia  Akhlaq,   Infect. 2006;12:24-39.
               Taha bin Ajaz Khan                                 doi: 10.1111/j.1469-0691.2006.01603.x
            Writing–review & editing: Zuhaa Rehman, Suneel Kumar
                                                               7.   Shamim MS, Siddiqui AA, Enam SA, Shah AA, Jooma R,
            Ethics approval and consent to participate            Anwar S. Craniocerebral aspergillosis in immunocompetent
                                                                  hosts: Surgical perspective. Neurol India. 2007;55(3):274-281.
            This study was approved by the Institutional Review Board
            Committee of JPMC under the IRB number NO.F.2-        doi: 10.4103/0028-3886.35689
            81/2023-GENL/92/JPMC.                              8.   Haddad E, Fekkar A, Bonnin S,  et al. Cerebral vasculitis
                                                                  due  to  Aspergillus spp. in  immunocompromised  patients:
            Consent for publication                               Literature review. Int J Infect Dis. 2022;122:244-251.

            The retrospective case series was conducted using      doi: 10.1016/j.ijid.2022.05.056
            deidentified data from the department registry. Hence,   9.  Santana-Ramírez  A,  Esparza-Gutiérrez  SV,
            consent for publication was not required.             Avila-Rodríguez  P, Jiménez-Gómez J.E, Vélez-Gómez E,
                                                                  Bañuelos-Gallo D. Aspergillosis of the central nervous system
            Availability of data                                  in a previously healthy patient that simulated Creutzfeldt-
            The data can be shared on request.                    Jakob disease. Surg Neurol Int. 2016;7(40):S940-S946.
                                                                  doi: 10.4103/2152-7806.195230
            Further disclosure
                                                               10.  Lamoth, F. Galactomannan and 1,3-β-d-glucan testing
            Part of or the entire set of findings has been presented in   for the diagnosis of invasive aspergillosis. J Fungi (Basel).
            a conference – 9  Annual Neuroscience Conference. The   2016;2(3):22.
                         th

             Volume 8 Issue 2 (2025)                       100                               doi: 10.36922/itps.4528
   101   102   103   104   105   106   107   108   109   110   111